Hints and tips:
Related Special Reports
...Now based in Leverkusen — whose Bayer-owned football club could win the Bundesliga for the first time in its 120-year history — the executive is drawing on close to 30 years of experience in pharma and biotech...
...In a strategy update on Tuesday, chief executive Bill Anderson said that the maker of Aspirin and Roundup would “keep an open mind” over a potential split....
...Its initial proposal is for an allocation of up to 5 per cent, or almost $80bn — alone more than all of Apollo’s private equity business....
...Worse still, the group blamed the slump on the all-important Asia-Pacific consumer, the health of which keeps sector investors up at night. That’s given rise to a predictable slew of luxury concerns....
...Exclusivity on its two top-selling drugs will start to expire in two years, yet many of Bayer’s deals have been for early stage assets that will take time to produce results....
...“We’ve heard from our bond investors [that] they don’t like the talk of a split up,” he said, adding that the allocation of Bayer’s €34.5bn in debt on separate entities would have created “some strange leverage...
...Bayer paid out a dividend of €2.40 for 2022....
...Bayer will report full-year results on March 5, when Anderson will also give an update on his strategic plans....
...Compared with all other consumer products — such as drugs and medical devices — Roundup has been the most targeted TV advertising since August, the firm said....
...Investors had long pushed Bayer to break itself into three separate groups, but Anderson said the expected loss of its exclusivity on key drugs, high debt, costly Roundup weedkiller litigation and the group...
...Among other options, Bayer has considered a carve-out of the consumer health unit, which specialises in over-the-counter medication, in order to streamline its business and raise much-needed cash....
...But after 20 criminal enforcement actions against companies, there have been just two individual convictions: one for a minor offence and the other of someone for receiving bribes, not paying them....
...A jury in Philadelphia ruled against Bayer on Friday in a case involving its Roundup weedkiller, according to a lawyer involved in the lawsuit....
...The group’s head of pharma, Stefan Oelrich, who moved to the job from rival Sanofi in 2018, axed 40 per cent of the old R&D programme, focusing on cell and gene therapy and spending billions of euros to...
...But putting Thames Water into a special administration regime — and quickly — would have its benefits.To be clear, a scenario where Thames is run temporarily by a special administrator on behalf of the UK...
...Leverkusen, which is owned by chemicals company Bayer, is one of a handful of exceptions....
...When the choreographer John Cranko died at the age of only 45, his colleague, rival and friend Kenneth MacMillan immortalised him with Requiem, one of his loveliest, most poignant works, which supplies the...
...Manon is built on generous lines with plum roles at all levels, creating stage pictures of Hogarthian vitality....
...But even optimists would struggle with no direction at all on Bayer’s future structure....
...Last month he blasted Bayer’s performance as “unacceptable” and stressed that “all options” were on the table, including splitting the pharma unit from the crop science division....
...Anderson said on Wednesday that the company has decided against a three-way split of its divisions but continues to evaluate other scenarios....
...Bayer’s pharma unit is facing the expiry of patents on some of its best-selling drugs, including its anti-clotting medication Xarelto, and had high hopes for asundexian....
...Anderson, who has led Bayer since June after joining from Swiss drugmaker Roche, has previously said that all options were on the table but on Wednesday narrowed those down, ruling out breaking the group...
...Over the weekend, Bayer also lost a key court case in the US on weed killer Roundup, which it acquired via its merger with Monsanto....
...He said that unless the weaknesses of this system were addressed, countries would “deal with each other individually . . . and where there’s failure in bilateral negotiations, where should countries go to...
International Edition